类癌性心脏病
本文综述类癌性心脏病的临床特征与处理:类癌综合征患者中超过50%发生类癌性心脏病,医学治疗限于症状控制与姑息,对有症状且转移性类癌综合征控制良好者应考虑瓣膜手术,需多学科管理。
要点
- 类癌性心脏病见于超过50%的类癌综合征患者,高达20%以心脏表现首诊。
- 瓣膜功能异常可致水肿、腹水和右心衰竭,医学治疗仅限症状控制与姑息。
- 有症状且转移性类癌综合征控制良好者应考虑瓣膜手术,需多学科管理。
核心结论
- 类癌性心脏病在类癌综合征患者中发生率高,医学治疗有限,部分患者可考虑瓣膜手术。
研究设计与样本
- 本文为综述,总结类癌性心脏病的临床特征与治疗策略。
主要发现
- 类癌综合征表现为血管舒缩改变、胃肠动力亢进、低血压和支气管痉挛。
- 类癌性心脏病见于超过50%的类癌综合征患者,高达20%的患者以心脏表现首诊。
- 典型病变为斑块样沉积物,由平滑肌细胞、肌成纤维细胞、细胞外基质及表面内皮层组成,可致瓣膜功能异常。
- 瓣膜功能异常可导致水肿、腹水和右心衰竭。
关键数值与推荐
- 类癌综合征的医学治疗(通常为生长抑素类似物)有助于控制症状、抑制肿瘤进展和延长生存。
- 类癌性心脏病的医学治疗限于症状控制和姑息。
- 对有症状且转移性类癌综合征控制良好的患者,应考虑瓣膜手术。
临床怎么用
- 类癌综合征患者应评估是否合并类癌性心脏病。
- 类癌性心脏病医学治疗以症状控制和姑息为主。
- 有症状且转移性类癌综合征控制良好者可考虑瓣膜手术,并需多学科管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rare neuroendocrine tumours (NETs) that most commonly arise in the gastrointestinal tract can lead to carcinoid syndrome and carcinoid heart disease. Patients with carcinoid syndrome present with vasomotor changes, hypermotility of the gastrointestinal system, hypotension and bronchospasm. Medical therapy for carcinoid syndrome, typically with somatostatin analogues, can help control symptoms, inhibit tumour progression and prolong survival. Carcinoid heart disease occurs in more than 50% of these patients and is the initial presentation of carcinoid syndrome in up to 20% of patients. Carcinoid heart disease has characteristic findings of plaque-like deposits composed of smooth muscle cells, myofibroblasts, extracellular matrix and an overlying endothelial layer which can lead to valve dysfunction. Valvular dysfunction can lead to oedema, ascites and right-sided heart failure. Medical therapy of carcinoid heart disease is limited to symptom control and palliation. Valve surgery for carcinoid heart disease should be considered for symptomatic patients with controlled metastatic carcinoid syndrome. A multidisciplinary approach is needed to guide optimal management.
引用
- Hassan SA, Banchs J, Iliescu C, et al. Carcinoid heart disease. Heart. 2017. PMID: 28596302. doi:10.1136/heartjnl-2017-311261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。